{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:49:41Z","timestamp":1770331781521,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ30742"],"award-info":[{"award-number":["2023JJ30742"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-35523-4","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T05:03:28Z","timestamp":1768021408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prior pulmonary tuberculosis deteriorated all-cause mortality in AECOPD patients after discharge"],"prefix":"10.1038","volume":"16","author":[{"given":"Ruoyan","family":"Xiong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiankang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huihui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"35523_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S2213-2600(21)00511-7","volume":"10","author":"D 1 Adeloye","year":"2022","unstructured":"1 Adeloye, D. et al. Global, regional, and National prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 10, 447\u2013458. https:\/\/doi.org\/10.1016\/S2213-2600(21)00511-7 (2022).","journal-title":"Lancet Respir Med."},{"key":"35523_CR2","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","volume":"388","author":"GBD 2 Mortality","year":"2016","unstructured":"2 Mortality, G. B. D. Causes of Death, C. global, regional, and National life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the global burden of disease study 2015. Lancet 388, 1459\u20131544. https:\/\/doi.org\/10.1016\/S0140-6736(16)31012-1 (2016).","journal-title":"Lancet"},{"key":"35523_CR3","unstructured":"3 WHO. The top 10 causes of death. (2020)."},{"key":"35523_CR4","unstructured":"4 WHO. Chronic obstructive pulmonary disease (COPD)."},{"key":"35523_CR5","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/S0140-6736(18)30841-9","volume":"391","author":"C 5 Wang","year":"2018","unstructured":"5 Wang, C. et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China pulmonary health [CPH] study): a National cross-sectional study. Lancet 391, 1706\u20131717. https:\/\/doi.org\/10.1016\/S0140-6736(18)30841-9 (2018).","journal-title":"Lancet"},{"key":"35523_CR6","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1183\/09031936.00142414","volume":"45","author":"PG 6 Burney","year":"2015","unstructured":"6 Burney, P. G., Patel, J., Newson, R., Minelli, C. & Naghavi, M. Global and regional trends in COPD mortality, 1990\u20132010. Eur. Respir J. 45, 1239\u20131247. https:\/\/doi.org\/10.1183\/09031936.00142414 (2015).","journal-title":"Eur. Respir J."},{"key":"35523_CR7","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/S0140-6736(22)00470-6","volume":"399","author":"SA Christenson","year":"2022","unstructured":"Christenson, S. A., Smith, B. M., Bafadhel, M., Putcha, N. & 7,, & Chronic obstructive pulmonary disease. Lancet 399, 2227\u20132242. https:\/\/doi.org\/10.1016\/S0140-6736(22)00470-6 (2022).","journal-title":"Lancet"},{"key":"35523_CR8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pccm.2025.05.004","volume":"3","author":"F 8 Dong","year":"2025","unstructured":"8 Dong, F. & Ren, R. S. Y. Burden of chronic obstructive pulmonary disease and risk factors in China from 1990 to 2021: analysis of global burden of disease 2021. Chin. Med. J. Pulmonary Crit. Care Med. 3, 132\u2013140 (2025).","journal-title":"Chin. Med. J. Pulmonary Crit. Care Med."},{"key":"35523_CR9","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1164\/rccm.202108-1819PP","volume":"204","author":"BR 9 Celli","year":"2021","unstructured":"9 Celli, B. R. et al. An updated definition and severity classification of chronic obstructive pulmonary disease exacerbations: the Rome proposal. Am. J. Respir Crit. Care Med. 204, 1251\u20131258. https:\/\/doi.org\/10.1164\/rccm.202108-1819PP (2021).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"35523_CR10","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1136\/thx.2005.040527","volume":"60","author":"JJ Soler-Cataluna","year":"2005","unstructured":"Soler-Cataluna, J. J. et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60, 925\u2013931. https:\/\/doi.org\/10.1136\/thx.2005.040527 (2005).","journal-title":"Thorax"},{"key":"35523_CR11","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1001\/archinternmed.2011.530","volume":"171","author":"I Alia","year":"2011","unstructured":"Alia, I. et al. Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support. Arch. Intern. Med. 171, 1939\u20131946. https:\/\/doi.org\/10.1001\/archinternmed.2011.530 (2011).","journal-title":"Arch. Intern. Med."},{"key":"35523_CR12","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1056\/NEJM199906243402502","volume":"340","author":"DE Niewoehner","year":"1999","unstructured":"Niewoehner, D. E. et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of veterans affairs cooperative study group. N Engl. J. Med. 340, 1941\u20131947. https:\/\/doi.org\/10.1056\/NEJM199906243402502 (1999).","journal-title":"N Engl. J. Med."},{"key":"35523_CR13","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","volume":"378","author":"DA Lipson","year":"2018","unstructured":"Lipson, D. A. et al. Once-Daily Single-Inhaler triple versus dual therapy in patients with COPD. N Engl. J. Med. 378, 1671\u20131680. https:\/\/doi.org\/10.1056\/NEJMoa1713901 (2018).","journal-title":"N Engl. J. Med."},{"key":"35523_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1916046","volume":"383","author":"KF Rabe","year":"2020","unstructured":"Rabe, K. F. et al. Triple inhaled therapy at two glucocorticoid doses in Moderate-to-Very-Severe COPD. N Engl. J. Med. 383, 35\u201348. https:\/\/doi.org\/10.1056\/NEJMoa1916046 (2020).","journal-title":"N Engl. J. Med."},{"key":"35523_CR15","unstructured":"WHO & Tuberculosis (2021)."},{"key":"35523_CR16","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/S2214-109X(22)00456-9","volume":"11","author":"B Knox-Brown","year":"2023","unstructured":"Knox-Brown, B. et al. Small airways obstruction and its risk factors in the burden of obstructive lung disease (BOLD) study: a multinational cross-sectional study. Lancet Glob Health. 11, e69\u2013e82. https:\/\/doi.org\/10.1016\/S2214-109X(22)00456-9 (2023).","journal-title":"Lancet Glob Health"},{"key":"35523_CR17","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0140-6736(09)61303-9","volume":"374","author":"SS Salvi","year":"2009","unstructured":"Salvi, S. S. & Barnes, P. J. Chronic obstructive pulmonary disease in non-smokers. Lancet 374, 733\u2013743. https:\/\/doi.org\/10.1016\/S0140-6736(09)61303-9 (2009).","journal-title":"Lancet"},{"key":"35523_CR18","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1378\/chest.13-2137","volume":"145","author":"YH Dong","year":"2014","unstructured":"Dong, Y. H. et al. Use of inhaled corticosteroids in patients with COPD and the risk of TB and influenza: A systematic review and meta-analysis of randomized controlled trials. A systematic review and meta-analysis of randomized controlled trials. Chest 145, 1286\u20131297. https:\/\/doi.org\/10.1378\/chest.13-2137 (2014).","journal-title":"Chest"},{"key":"35523_CR19","doi-asserted-by":"publisher","unstructured":"Lee, C. M. et al. Inhaled Corticosteroid-Related Tuberculosis in the Real World Among Patients with Asthma and COPD: A 10-Year Nationwide Population-Based Study. J Allergy Clin Immunol Pract 7, 1197\u20131206 e1193 (2019). https:\/\/doi.org\/10.1016\/j.jaip.2018.10.007","DOI":"10.1016\/j.jaip.2018.10.007"},{"key":"35523_CR20","unstructured":"Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). (2025). https:\/\/goldcopd.org\/2025-gold-report\/(accessed Feb 13, 2025)."},{"key":"35523_CR21","unstructured":"Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). (2024). https:\/\/goldcopd.org\/archived-reports\/(accessed Jan 9, 2026)."},{"key":"35523_CR22","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S2213-2600(17)30207-2","volume":"5","author":"MK Han","year":"2017","unstructured":"Han, M. K. et al. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. Lancet Respir Med. 5, 619\u2013626. https:\/\/doi.org\/10.1016\/S2213-2600(17)30207-2 (2017).","journal-title":"Lancet Respir Med."},{"key":"35523_CR23","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","volume":"363","author":"JR Hurst","year":"2010","unstructured":"Hurst, J. R. et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl. J. Med. 363, 1128\u20131138. https:\/\/doi.org\/10.1056\/NEJMoa0909883 (2010).","journal-title":"N Engl. J. Med."},{"key":"35523_CR24","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/09031936.00102509","volume":"34","author":"PW Jones","year":"2009","unstructured":"Jones, P. W. et al. Development and first validation of the COPD assessment test. Eur. Respir J. 34, 648\u2013654. https:\/\/doi.org\/10.1183\/09031936.00102509 (2009).","journal-title":"Eur. Respir J."},{"key":"35523_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/thx.54.7.581","volume":"54","author":"JC Bestall","year":"1999","unstructured":"Bestall, J. C. et al. Usefulness of the medical research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54, 581\u2013586. https:\/\/doi.org\/10.1136\/thx.54.7.581 (1999).","journal-title":"Thorax"},{"key":"35523_CR26","unstructured":"Global strategy for prevention, diagnosis and management of copd: 2025 Report, https:\/\/goldcopd.org\/2025-gold-report\/ (."},{"key":"35523_CR27","unstructured":"WHO. Global Tuberculosis Report 2022."},{"key":"35523_CR28","doi-asserted-by":"publisher","first-page":"e37978","DOI":"10.1371\/journal.pone.0037978","volume":"7","author":"CH Lee","year":"2012","unstructured":"Lee, C. H. et al. Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronic obstructive pulmonary disease. PLoS One. 7, e37978. https:\/\/doi.org\/10.1371\/journal.pone.0037978 (2012).","journal-title":"PLoS One"},{"key":"35523_CR29","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1183\/13993003.02325-2014","volume":"46","author":"AF Amaral","year":"2015","unstructured":"Amaral, A. F. et al. Tuberculosis associates with both airflow obstruction and low lung function: BOLD results. Eur. Respir J. 46, 1104\u20131112. https:\/\/doi.org\/10.1183\/13993003.02325-2014 (2015).","journal-title":"Eur. Respir J."},{"key":"35523_CR30","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1136\/thoraxjnl-2020-216500","volume":"77","author":"K Kamenar","year":"2022","unstructured":"Kamenar, K. et al. Previous tuberculosis disease as a risk factor for chronic obstructive pulmonary disease: a cross-sectional analysis of multicountry, population-based studies. Thorax 77, 1088\u20131097. https:\/\/doi.org\/10.1136\/thoraxjnl-2020-216500 (2022).","journal-title":"Thorax"},{"key":"35523_CR31","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1378\/chest.09-1435","volume":"137","author":"KB Lam","year":"2010","unstructured":"Lam, K. B. et al. Prior TB, smoking, and airflow obstruction: a cross-sectional analysis of the Guangzhou biobank cohort study. Chest 137, 593\u2013600. https:\/\/doi.org\/10.1378\/chest.09-1435 (2010).","journal-title":"Chest"},{"key":"35523_CR32","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2147\/COPD.S152447","volume":"13","author":"J Jin","year":"2018","unstructured":"Jin, J., Li, S., Yu, W., Liu, X. & Sun, Y. Emphysema and bronchiectasis in COPD patients with previous pulmonary tuberculosis: computed tomography features and clinical implications. Int. J. Chron. Obstruct Pulmon Dis. 13, 375\u2013384. https:\/\/doi.org\/10.2147\/COPD.S152447 (2018).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"35523_CR33","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1378\/chest.12-1225","volume":"143","author":"JH Kim","year":"2013","unstructured":"Kim, J. H. et al. Inhaled corticosteroid is associated with an increased risk of TB in patients with COPD. Chest 143, 1018\u20131024. https:\/\/doi.org\/10.1378\/chest.12-1225 (2013).","journal-title":"Chest"},{"key":"35523_CR34","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.2147\/COPD.S325097","volume":"16","author":"Y Liang","year":"2021","unstructured":"Liang, Y. et al. Clinical and radiological features of COPD patients living at >\/=3000 m above sea level in the Tibet plateau. Int. J. Chron. Obstruct Pulmon Dis. 16, 2445\u20132454. https:\/\/doi.org\/10.2147\/COPD.S325097 (2021).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"35523_CR35","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/1471-2334-13-194","volume":"13","author":"CH Lee","year":"2013","unstructured":"Lee, C. H. et al. Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in taiwan: a nationwide cohort study. BMC Infect. Dis. 13, 194. https:\/\/doi.org\/10.1186\/1471-2334-13-194 (2013).","journal-title":"BMC Infect. Dis."},{"key":"35523_CR36","doi-asserted-by":"publisher","unstructured":"Walters, J. A. et al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. CD001288 https:\/\/doi.org\/10.1002\/14651858.CD001288.pub4 (2014).","DOI":"10.1002\/14651858.CD001288.pub4"},{"key":"35523_CR37","doi-asserted-by":"publisher","first-page":"e000407","DOI":"10.1136\/bmjresp-2019-000407","volume":"6","author":"P Sivapalan","year":"2019","unstructured":"Sivapalan, P. et al. COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months. BMJ Open. Respir Res. 6, e000407. https:\/\/doi.org\/10.1136\/bmjresp-2019-000407 (2019).","journal-title":"BMJ Open. Respir Res."},{"key":"35523_CR38","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1136\/thoraxjnl-2012-203175","volume":"68","author":"CH Lee","year":"2013","unstructured":"Lee, C. H. et al. Use of inhaled corticosteroids and the risk of tuberculosis. Thorax 68, 1105\u20131113. https:\/\/doi.org\/10.1136\/thoraxjnl-2012-203175 (2013).","journal-title":"Thorax"},{"key":"35523_CR39","doi-asserted-by":"publisher","unstructured":"Nannini, L. J., Poole, P., Milan, S. J. & Kesterton, A. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease. Cochrane Database Syst Rev CD006826 (2013). (2013). https:\/\/doi.org\/10.1002\/14651858.CD006826.pub2","DOI":"10.1002\/14651858.CD006826.pub2"},{"key":"35523_CR40","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/S0140-6736(18)30206-X","volume":"391","author":"A Papi","year":"2018","unstructured":"Papi, A. et al. Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial. Lancet 391, 1076\u20131084. https:\/\/doi.org\/10.1016\/S0140-6736(18)30206-X (2018).","journal-title":"Lancet"},{"key":"35523_CR41","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1164\/rccm.201007-1099OC","volume":"183","author":"P Brassard","year":"2011","unstructured":"Brassard, P., Suissa, S., Kezouh, A. & Ernst, P. Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases. Am. J. Respir Crit. Care Med. 183, 675\u2013678. https:\/\/doi.org\/10.1164\/rccm.201007-1099OC (2011).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"35523_CR42","doi-asserted-by":"publisher","first-page":"e10138","DOI":"10.1371\/journal.pone.0010138","volume":"5","author":"M Inghammar","year":"2010","unstructured":"Inghammar, M. et al. COPD and the risk of tuberculosis\u2013a population-based cohort study. PLoS One. 5, e10138. https:\/\/doi.org\/10.1371\/journal.pone.0010138 (2010).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35523-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35523-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35523-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:19:52Z","timestamp":1770286792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35523-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35523"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35523-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4970"}}